Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.

Literature DB >> 28607835

The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.

Cherie Chu¹, Louis Lteif¹, Nicole Young¹.

Abstract

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2017 PMID： 28607835 PMCID： PMC5458583

Source DB: PubMed Journal: Hawaii J Med Public Health ISSN： 2165-8242

Keyword Cloud
References

× No keyword cloud information.

36 in total

1. Dosing of piperacillin/tazobactam in a morbidly obese patient.

Authors: Hanna Deman; Jan Verhaegen; Ludo Willems; Isabel Spriet
Journal: J Antimicrob Chemother Date: 2011-11-30 Impact factor: 5.790

Review 2. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors:
Journal: Obes Res Date: 1998-09

Review 3. Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age.

Authors: Leo F Buckley; Eva Rybak; Ahmed Aldemerdash; Judy W M Cheng; John Fanikos
Journal: Clin Cardiol Date: 2016-10-07 Impact factor: 2.882

4. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults.

Authors: M Chen; A N Nafziger; G L Drusano; L Ma; J S Bertino
Journal: Antimicrob Agents Chemother Date: 2006-04 Impact factor: 5.191

5. The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE).

Authors: R Barba; J Marco; H Martín-Alvarez; P Rondon; C Fernández-Capitan; F Garcia-Bragado; M Monreal
Journal: J Thromb Haemost Date: 2005-05 Impact factor: 5.824

The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.

1. Dosing of piperacillin/tazobactam in a morbidly obese patient.

Review 2. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Review 3. Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age.

4. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults.

5. The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE).

6. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery.

7. Development of a dosing strategy for enoxaparin in obese patients.

Review 8. Effect of obesity on the pharmacokinetics of drugs in humans.

9. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia.

10. Antibiotic dosing in obesity: a BIG challenge.